HALT-IT - tranexamic acid for the treatment of gastrointestinal bleeding: study protocol for a randomised controlled trial

[1]  C. Fenger-Eriksen,et al.  [Tranexamic acid for upper gastrointestinal bleeding]. , 2016, Ugeskrift for laeger.

[2]  L. Gluud,et al.  Tranexamic acid for upper gastrointestinal bleeding. , 2014, The Cochrane database of systematic reviews.

[3]  I. Roberts,et al.  How effective is tranexamic acid for acute gastrointestinal bleeding? , 2014, BMJ : British Medical Journal.

[4]  Phil Edwards,et al.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis , 2012, BMJ : British Medical Journal.

[5]  A. Barkun,et al.  Improving outcomes from acute upper gastrointestinal bleeding , 2012, Gut.

[6]  C. Guerriero,et al.  Cost-Effectiveness Analysis of Administering Tranexamic Acid to Bleeding Trauma Patients Using Evidence from the CRASH-2 Trial , 2011, PloS one.

[7]  Cornelius Lehane,et al.  High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement. , 2011, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  S. Travis,et al.  Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit , 2011, Gut.

[9]  F. Chan,et al.  Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding , 2011, Gut.

[10]  G. Guyatt,et al.  The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial , 2011, The Lancet.

[11]  M. Goldacre,et al.  Hospitalized incidence and case fatality for upper gastrointestinal bleeding from 1999 to 2007: a record linkage study , 2011, Alimentary pharmacology & therapeutics.

[12]  A. McDonald,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial , 2010, The Lancet.

[13]  J. Murkin,et al.  High-Dose Tranexamic Acid Is Associated with Nonischemic Clinical Seizures in Cardiac Surgical Patients , 2010, Anesthesia and analgesia.

[14]  R. Hunt,et al.  International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding , 2010, Annals of Internal Medicine.

[15]  H. Messmann,et al.  Diagnosis and management of lower gastrointestinal bleeding , 2009, Nature Reviews Gastroenterology &Hepatology.

[16]  Á. Lanas,et al.  Mortality with upper gastrointestinal bleeding and perforation: effects of time and NSAID use , 2009, BMC gastroenterology.

[17]  M. Shelkey,et al.  Monitoring Functional Status in Hospitalized Older Adults , 2008, The American journal of nursing.

[18]  A. Edwards,et al.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence , 2007, Gut.

[19]  L. S. Friedman,et al.  Review article: the management of lower gastrointestinal bleeding , 2005, Alimentary pharmacology & therapeutics.

[20]  Sydes,et al.  A proposed charter for clinical trial data monitoring committees: helping them to do their job well , 2005, The Lancet.

[21]  R. Poupon,et al.  Improved survival after variceal bleeding in patients with cirrhosis over the past two decades , 2004, Hepatology.

[22]  A. Barkun,et al.  The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting , 2004, American Journal of Gastroenterology.

[23]  G. D’Amico,et al.  Upper digestive bleeding in cirrhosis. Post‐therapeutic outcome and prognostic indicators , 2003, Hepatology.

[24]  J. Habbema,et al.  Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. , 2003, Acta tropica.

[25]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[26]  David Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials , 2001, Annals of Internal Medicine.

[27]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[28]  Justin C.Y. Wu,et al.  Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. , 2000, The New England journal of medicine.

[29]  R Peto,et al.  Trials: the next 50 years , 1998, BMJ.

[30]  G. Longstreth.  Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: a population-based study. , 1997, The American journal of gastroenterology.

[31]  H B Devlin,et al.  Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom , 1995 .

[32]  D. V. Van Riper,et al.  The Dose‐Response Relationship of Tranexamic Acid , 1995, Anesthesiology.

[33]  D. Ketley,et al.  Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction , 1993, The Lancet.

[34]  G. Lowe,et al.  Association of fibrinolytic tests with outcome of acute upper-gastrointestinal-tract bleeding , 1993, The Lancet.

[35]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[36]  J. Haybittle,et al.  Repeated assessment of results in clinical trials of cancer treatment. , 1971, The British journal of radiology.

[37]  Andy Gray,et al.  The selection and use of essential medicines. , 2008, World Health Organization technical report series.

[38]  G. Gravlee.  High-Dose Tranexamic Acid Is an Independent Predictor of Early Seizure After Cardiopulmonary Bypass , 2012 .

[39]  A. Menkis,et al.  Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors , 2011, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[40]  A. Laupacis,et al.  Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. , 2001, The Cochrane database of systematic reviews.

[41]  K. Goa,et al.  Tranexamic acid: a review of its use in surgery and other indications. , 1999, Drugs.

[42]  H B Devlin,et al.  Incidence of and mortality from acute upper gastrointestinal haemorrhage in the United Kingdom. Steering Committee and members of the National Audit of Acute Upper Gastrointestinal Haemorrhage. , 1995, BMJ.

[43]  C R Prentice,et al.  Basis of antifibrinolytic therapy , 1980, Journal of clinical pathology. Supplement.